Plasma CRP levels in premenopausal women with major depression: A 12-month controlled study

Hormone and Metabolic Research

Volumn 41, Issue 8, 2009, Pages 641-648

  Cizza, G ^a   Eskandari, F ^a   Coyle, M ^a   Krishnamurthy, P ^a   Wright, E C ^b   Mistry, S ^a   Csako, G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Cardiovascular morbidity; Cytokine; Inflammation; Metabolic syndrome; Obesity; Women's health

Indexed keywords

C REACTIVE PROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; BODY COMPOSITION; BODY MASS; BONE TURNOVER; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROLOGY; ADULT; BLOOD; DEPRESSION; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT;

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; DEPRESSIVE DISORDER; FEMALE; HUMANS; MIDDLE AGED; PREMENOPAUSE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70349562398     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1220717     Document Type: Article

References (52)

1. Carney RM, Rich MW, Tevelde A, Saini J, Clark K, Jaffe AS. Major depressive disorder in coronary artery disease. Am J Cardiol 1987 60 1273-1275
2. Gonzalez MB, Snyderman TB, Colket JT, Arias RM, Jiang JW, OConnor CM, Krishnan KR. Depression in patients with coronary artery disease. Depression 1996 4 57-62
3. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study National Health and Nutrition Examination Survey. Arch Intern Med 2000 160 1261-1268
4. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 2002 23 51-61
5. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med 2004 164 289-298
6. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002 90 1279-1283
7. Marques-Deak A, Cizza G, Sternberg E. Brain-immune interactions and disease susceptibility. Mol Psychiatry 2005 10 239-250
8. Eskandari F, Mistry S, Martinez PE, Torvik S, Kotila C, Sebring N, Drinkard BE, Levy C, Reynolds JC, Csako G, Gold PW, Horne M, Cizza G, POWER (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group. Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. Metabolism 2005 54 918-924
9. Agatisa PK, Matthews KA, Bromberger JT, Edmundowicz D, Chang YF, Sutton-Tyrrell K. Coronary and aortic calcification in women with a history of major depression. Arch Intern Med 2005 165 1229-1236
10. Jones DJ, Bromberger JT, Sutton-Tyrrell K, Matthews KA. Lifetime history of depression and carotid atherosclerosis in middle-aged women. Arch Gen Psychiatry 2003 60 153-160
11. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000 342 836-843 (Pubitemid 30165206)
12. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004 109 2818-2825
13. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive proteinand low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002 347 1557-1565
14. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003 54 566-572 (Pubitemid 37289443)
15. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002 90 1279-1283
16. Berk M, Wadee AA, Kuschke RH, ONeill-Kerr A. Acute phase proteins in major depression. J Psychosom Res 1997 43 529-534
17. Frasure-Smith N, Lesperance F, Irwin MR, Sauve C, Lesperance J, Theroux P. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 2007 62 302-308
18. Huang TL, Lin FC. High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania. Prog Neuropsychopharmacol Biol Psychiatry 2007 31 370-372
19. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P, PRIME Study Group. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005 111 2299-2305
20. Panagiotakos DB, Pitsavos C, Chrysohoou C, Tsetsekou E, Papageorgiou C, Christodoulou G, Stefanadis C, ATTICA study. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J 2004 25 492-499
21. Kling MA, Alesci S, Csako G, Costello R, Luckenbaugh DA, Bonne O, Duncko R, Drevets WC, Manji HK, Charney DS, Gold PW, Neumeister A. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biol Psychiatry 2007 62 309-313
22. Dogan E, Erkoc R, Eryonucu B, Sayarlioglu H, Agargun MY. Relation between depression, some laboratory parameters, and quality of life in hemodialysis patients. Ren Fail 2005 27 695-699
23. OBrien SM, Scott LV, Dinan TG. Antidepressant therapy and C-reactive protein levels. Br J Psychiatry 2006 188 449-452
24. Lesperance F, Frasure-Smith N, Theroux P, Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004 161 271-277
25. Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 2003 78 40-46
26. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005 4 371-380
27. Henningsson S, Baghaei F, Rosmond R, Holm G, Landén M, Anckarsäter H, Ekman A. Association between serum levels of C-reactive protein and personality traits in women. Behav Brain Funct 2008 4 16
28. Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry 2007 62 314-320 (Pubitemid 47444281)
29. Pan A, Ye X, Franco OH, Li H, Yu Z, Wang J, Qi Q, Gu W, Pang X, Liu H, Lin X. The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS ONE 2008 3 e1392
30. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush JA, Walter EE, Wang PS. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003 289 3095-3105
31. Riese H, Vrijkotte TG, Meijer P, Kluft C, De Geus EJ. Diagnostic strategies for C-reactive protein. BMC Cardiovasc Disord 2002 2 9
32. Rudnicka AR, Rumley A, Lowe GD, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 2007 115 996-1003
33. Eskandari F, Martinez P, Torvik S, Phillips TM, Sternberg EM, Mistry S, Ronsaville D, Wesley R, Toomey C, Sebring NG, Reynolds JC, Blackman MC, Calis KA, Gold PW, Cizza G, for the Power Study Group. Low bone mass in premenopausal women with depression. Arch Intern Med 2007 167 2329-2336
34. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E, PEACE Investigators. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 2007 115 1528-1536
35. Ladwig KH, Marten-Mittag B, Lowel H, Doring A, Koenig W. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav Immun 2003 17 268-275
36. Dietrich T, Garcia RI, de Pablo P, Schulze PC, Hoffmann K. The effects of cigarette smoking on C-reactive protein concentrations in men and women and its modification by exogenous oral hormones in women. Eur J Cardiovasc Prev Rehabil 2007 14 694-700
37. Raum E, Gebhardt K, Buchner M, Schiltenwolf M, Brenner H. Long-term and short-term alcohol consumption and levels of C-reactive protein. Int J Cardiol 2007 121 224-226
38. Cizza G, Marques AH, Eskandari F, Christie IC, Torvik S, Silverman MN, Phillips TM, Sternberg EM. POWER Study Group. Elevated neuroimmune biomarkers in sweat patches and plasma in premenopausal women with major depressive disorder in remission: the POWER Study. Biol Psychiatry 2008 Nov 15 64 (10) 907-911 Epub 2008 Jul 26
39. Devaraj S, OKeefe G, Jialal I. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab 2005 90 4549-4554
40. Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM. Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension 2007 49 304-310
41. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006 145 21-29
42. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997 82 4196-4200
43. Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004 66 316-322
44. Jensen GL. Drug-induced hyperphagia: what can we learn from psychiatric medications? J Parenter Enteral Nutr 2008 32 578-581
45. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005 294 326-333
46. Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Bertrand F, Dagenais GR, Brophy JM. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. J Am Coll Cardiol 2008 51 2339-2346
47. Kluft C, de Maat MP. Determination of the habitual low blood level of C-reactive protein in individuals. Ital Heart J 2001 3 172-180
48. Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney Jr JF, Wilson PW, Newton-Cheh C, Musone SL, Camargo AL, Drake JA, Levy D, ODonnell CJ, Hirschhorn JN, Benjamin EJ. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006 113 1415-1423
49. Kelly GS. Seasonal variations of selected cardiovascular risk factors. Altern Med Rev 2005 10 307-320
50. Kao PC, Shiesh SC, Wu TJ. Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci 2006 36 163-169
51. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000 22 370-379
52. Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 2007 167 31-39